BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 20501751)

  • 1. Risk factors for ductal, lobular, and mixed ductal-lobular breast cancer in a screening population.
    Phipps AI; Li CI; Kerlikowske K; Barlow WE; Buist DS
    Cancer Epidemiol Biomarkers Prev; 2010 Jun; 19(6):1643-54. PubMed ID: 20501751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reproductive risk factor associations with lobular and ductal carcinoma in the Carolina Breast Cancer Study.
    Williams LA; Nichols HB; Hoadley KA; Tse CK; Geradts J; Bell ME; Perou CM; Love MI; Olshan AF; Troester MA
    Cancer Causes Control; 2018 Jan; 29(1):25-32. PubMed ID: 29124544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of length of birth interval on the risk of breast cancer by subtype in grand multiparous women.
    Katuwal S; Tapanainen JS; Pukkala E; Kauppila A
    BMC Cancer; 2019 Mar; 19(1):199. PubMed ID: 30832620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterogeneity in risk factors for ductal and lobular breast carcinomas: A case-control study.
    Dianatinasab M; Fararouei M; Daneshi N; Rezaian S; Mohammadianpanah M; Chaman R; Ghiasvand R
    Int J Cancer; 2019 Dec; 145(11):2917-2925. PubMed ID: 30719718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prognosis of invasive ductal carcinoma, lobular carcinoma and mixed ductal and lobular carcinoma according to molecular subtypes of the breast.
    Zhao H
    Breast Cancer; 2021 Jan; 28(1):187-195. PubMed ID: 32812198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Do Body Mass Index and Breast Density Impact Cancer Risk Among Women with Lobular Carcinoma In Situ?
    Minami CA; Zabor EC; Gilbert E; Newman A; Park A; Jochelson MS; King TA; Pilewskie ML
    Ann Surg Oncol; 2020 Jun; 27(6):1844-1851. PubMed ID: 31898097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in race, molecular and tumor characteristics among women diagnosed with invasive ductal and lobular breast carcinomas.
    Williams LA; Hoadley KA; Nichols HB; Geradts J; Perou CM; Love MI; Olshan AF; Troester MA
    Cancer Causes Control; 2019 Jan; 30(1):31-39. PubMed ID: 30617775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mixed Invasive Ductal and Lobular Carcinoma of the Breast: Prognosis and the Importance of Histologic Grade.
    Metzger-Filho O; Ferreira AR; Jeselsohn R; Barry WT; Dillon DA; Brock JE; Vaz-Luis I; Hughes ME; Winer EP; Lin NU
    Oncologist; 2019 Jul; 24(7):e441-e449. PubMed ID: 30518616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dietary Patterns and Risk of Invasive Ductal and Lobular Breast Carcinomas: A Systematic Review and Meta-analysis.
    Dianatinasab M; Rezaian M; HaghighatNezad E; Bagheri-Hosseinabadi Z; Amanat S; Rezaeian S; Masoudi A; Ghiasvand R
    Clin Breast Cancer; 2020 Aug; 20(4):e516-e528. PubMed ID: 32362500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synchronous bilateral breast cancer: a nationwide study on histopathology and etiology.
    Mejdahl MK; Wohlfahrt J; Holm M; Knoop AS; Tjønneland A; Melbye M; Kroman N; Balslev E
    Breast Cancer Res Treat; 2020 Jul; 182(1):229-238. PubMed ID: 32441019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Population-based Study of Prosigna-PAM50 and Outcome Among Postmenopausal Women With Estrogen Receptor-positive and HER2-negative Operable Invasive Lobular or Ductal Breast Cancer.
    Lænkholm AV; Jensen MB; Eriksen JO; Roslind A; Buckingham W; Ferree S; Nielsen T; Ejlertsen B
    Clin Breast Cancer; 2020 Aug; 20(4):e423-e432. PubMed ID: 32253134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of metachronous contralateral breast cancer in patients with primary invasive lobular breast cancer: Results from a nationwide cohort.
    Akdeniz D; Kramer I; van Deurzen CHM; Heemskerk-Gerritsen BAM; Schaapveld M; Westenend PJ; Voogd AC; Jager A; Steyerberg EW; Sleijfer S; Schmidt MK; Hooning MJ
    Cancer Med; 2023 Feb; 12(3):3123-3133. PubMed ID: 36127572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breast cancer histologic subtypes show excess familial clustering.
    Henry NL; Cannon-Albright LA
    Cancer; 2019 Sep; 125(18):3131-3138. PubMed ID: 31120568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is There a Special Role for Ovarian Hormones in the Pathogenesis of Lobular Carcinoma?
    Flaherty RL; Sflomos G; Brisken C
    Endocrinology; 2024 Mar; 165(5):. PubMed ID: 38551031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cigarette smoking, physical activity, and alcohol consumption as predictors of cancer incidence among women at high risk of breast cancer in the NSABP P-1 trial.
    Land SR; Liu Q; Wickerham DL; Costantino JP; Ganz PA
    Cancer Epidemiol Biomarkers Prev; 2014 May; 23(5):823-32. PubMed ID: 24569437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metastatic pure invasive lobular breast cancer or metastatic mixed invasive ductal and lobular breast cancer: are they different entities?
    Altundag K
    Breast Cancer Res Treat; 2023 Apr; 198(3):623. PubMed ID: 36853578
    [No Abstract]   [Full Text] [Related]  

  • 17. Adherence to a western dietary pattern and risk of invasive ductal and lobular breast carcinomas: a case-control study.
    Foroozani E; Akbari A; Amanat S; Rashidi N; Bastam D; Ataee S; Sharifnia G; Faraouei M; Dianatinasab M; Safdari H
    Sci Rep; 2022 Apr; 12(1):5859. PubMed ID: 35393463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The 21-Gene Recurrence Score in Special Histologic Subtypes of Breast Cancer.
    Gulbahce HE; Downs-Kelly E; Herget KA; Stoddard GJ
    Arch Pathol Lab Med; 2022 Apr; 146(4):478-484. PubMed ID: 34343231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic Utility of Breast Cancer Index to Stratify Distant Recurrence Risk in Invasive Lobular Carcinoma.
    Nunes R; Sella T; Treuner K; Atkinson JM; Wong J; Zhang Y; Exman P; Dabbs D; Richardson AL; Schnabel CA; Sgroi DC; Oesterreich S; Cimino-Mathews A; Metzger O
    Clin Cancer Res; 2021 Oct; 27(20):5688-5696. PubMed ID: 34376532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ASO Author Reflections: Discordant Clinical and Molecular Risk in Invasive Lobular Carcinoma of the Breast: The 21-Gene Recurrence Score in the National Cancer Database by Histologic Subtype.
    Abel MK; Mukhtar RA
    Ann Surg Oncol; 2022 Nov; 29(12):7748-7749. PubMed ID: 35798894
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.